Skip to content

How Family Support and Health Education can Enhance Quality of Life for Pulmonary Tuberculosis patients in Puducherry-Randomized Control Trial

Effectiveness of Family Support Health Education Intervention to improve Health -Related Quality of Life among Drug Sensitive Pulmonary Tuberculosis patients in Puducherry-Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079434
Enrollment
136
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z201- Contact with and (suspected) exposure to tuberculosis

Interventions

Intervention1: Modified Family Support health education intervention: Family support health education Intervention to improve health related quality of life among drug sensitive pulmonary tuberculosis

Sponsors

Sri lakshmi narayana institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All newly diagnosed drug sensitive adult Pulmonary TB cases in the year of 2024 registered under NTEP, Puducherry irrespective of gender, receiving treatment from the selected PHCs 2. Patients of age more than 18 years. 3. Participants staying with family members (spouse, children, siblings, parents).

Exclusion criteria

Exclusion criteria: 1. Patients too ill to participate, and the cases of retreatment Pulmonary Tuberculosis. 2. Participants with other comorbid illness including HIV infection, diabetes and other chronic diseases. 3. Family member of the Pulmonary Tuberculosis who has been already recruited into this study.

Design outcomes

Primary

MeasureTime frame
Modified FASTEN will improve health related Quality of Life among newly diagnosed drug sensitive Pulmonary tuberculosisTimepoint: Baseline 2 months to 6 months

Secondary

MeasureTime frame
Modified FASTEN intervention will also have positive impact on treatment outcomeTimepoint: 6 months to 1 year

Countries

India

Contacts

Public ContactDr. Anithadevi K

SRI LAKSHMI NARAYANA INSTITUTE OF MEDICAL SCIENCES

drkannan83@gmail.com9786028602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026